Merck, known as MSD outside of the United States and Canada, announced the FDA has approved Lipfendra (enlicitide) tablets 20 mg as an adjunct to diet and exercise… read more.
MannKind Corporation announced that the FDA has approved Furoscix ReadyFlow (furosemide injection) for the treatment of edema (fluid overload) in adults with heart failure (HF) or chronic kidney… read more.
Johnson & Johnson announced that the FDA approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform (DE STSF), an integrated catheter ablation solution that enables electrophysiologists to deliver both… read more.
More people are living with severe obesity, and weight-loss medication is being used widely. But what does that mean for overall health beyond weight loss? A new study… read more.
Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the… read more.
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life and few show cardiovascular benefits at one year, finds… read more.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Leqvio… read more.
A novel economic model projects that patients with heart failure would live longer lives and spend less time in hospital by expanding heart failure care to include pharmacist-… read more.
An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance.1 These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society… read more.
Scientists at Queen Mary University of London and Barts Health NHS Trust have invented an AI algorithm which could transform how heart failure is screened and diagnosed. Known… read more.
Novo Nordisk presented post hoc analyses from the SELECT, STEP, ESSENCE, and OASIS clinical trials at the 2026 Scientific Sessions of the American Diabetes Association (ADA), highlighting data regarding the impact… read more.
Including blueberries, plums, blackberries, broad beans or cherries (washed down with green tea) in your five-a-day may be the best way to a healthier heart, new research suggests. A major research study involving scientists from the University of Reading, Harvard Medical… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
